Christopher Franco

Christopher Franco has a diverse work experience in the field of biopharmaceuticals and strategy consulting. Christopher is currently working at Coherus BioSciences as the Senior Vice President Corporate Development and Strategic Initiatives. Prior to this, they held various roles at Takeda, including Global Program Manager, Oncology/Cell Therapies, R&D Global Portfolio Strategy Lead, and Senior Director, Pipeline Strategy and Management. Christopher also worked at Blueprint Medicines as an Associate Director, Business Strategy, and at Leerink Partners as an Associate, Strategy Consulting. Before entering the industry, Christopher worked as a Postdoctoral Scientist at NGM Biopharmaceuticals and pursued an Immunology PhD at Stanford University.

Christopher Franco has a Ph.D. in Immunology from Stanford University. Christopher also received a Certificate from Stanford University Graduate School of Business in the Stanford Summer Institute for Entrepreneurship program. Prior to these achievements, Christopher earned a B.S. with Honors in Biology from Caltech.